Value Investor
Start free

Femasys

FEMY on Nasdaq. Market value $17m.

Watch this stockFree. We tell you when something changes.

Should I look at this?

We have not checked this company yet

This is not advice.

Compare with another stock

Who owns it

None of the long-term investors we follow own it. 18 funds in all.

Jun '25
Dec '25
Jun '26
Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

7 investors own more than 5%.

  • at least 10.0%
    (filed with 3 related holders)
    Since 10 August 2026
    What they said

    The disclosure regarding the SPA and the Purchase set forth above in Item 3 is incorporated herein by reference. The Issuer has further described the SPA, the Purchase and the Side Letter in a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the…

    Read the filing
  • Alumni Capital LP
    Passive investor
    at least 10.0%
    (filed with 2 related holders)
    Since 4 September 2025
  • Rosalind Advisors, Inc.
    Passive investor
    at least 9.9%
    (filed with 3 related holders)
    Since 10 August 2026
  • 9.9%+4.5 pts
    Since 30 September 2025
  • Chernett Jorey
    Passive investor
    9.3%+3.1 pts
    Since 30 June 2025
  • PharmaCyte Biotech, Inc.
    Passive investor
    7.9%
    Since 17 March 2026
  • at least 7.2%
    (filed with 3 related holders)
    Since 10 August 2026

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

In the last 12 months, 5 insiders bought $134,000 of shares on the open market.

Cluster buy5 insiders bought within 30 days (7 August 2026 to 7 August 2026).
  • Mifek Jeffrey Gerald
    Chief Clinical-Medical Affairs
    Bought
    Date
    7 August 2026
    Shares
    3,125
    Price
    $3.20
    Value
    $10,000
  • Sipos Jeremy Alexander
    Chief Technology Officer
    Bought
    Date
    7 August 2026
    Shares
    3,125
    Price
    $3.20
    Value
    $10,000
  • Canning John Charles
    Chief Operating Officer
    Bought
    Date
    7 August 2026
    Shares
    4,375
    Price
    $3.20
    Value
    $14,000
  • Elefant Dov
    Chief Financial Officer
    Bought
    Date
    7 August 2026
    Shares
    15,625
    Price
    $3.20
    Value
    $50,000
  • Lee-Sepsick Kathy
    Chief Executive Officer, Director
    Bought
    Date
    7 August 2026
    Shares
    15,625
    Price
    $3.20
    Value
    $50,000

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

None of the warning signs we check for were found.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 31 Mar 2026, plus the 10-Q filed 14 Aug 2026 and 10 later 8-Ks.

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from
Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.